Articles: disease.
-
Biomarkers are becoming crucial in ever more medical tasks and are proposed to change medicine in profound ways. By biomarking ever more attributes of human life, they tend to blur the distinction between health and disease and come to characterize life as such. Not only do biomarkers strongly influence the professional conception of disease by pervading ever more diagnoses, but they also impact patients' experience of illness. To manage how biomarkers influence patients, professionals, and societies, we urgently need to move from identifying potentially relevant biomarkers to determine their meaning and value to individuals, professionals, and public health.
-
Pol. Arch. Med. Wewn. · Jan 2025
Steatotic liver disease in patients treated for chronic hepatitis B.
Steatotic liver disease (SLD) can worsen the prognosis of other chronic liver diseases, including viral hepatitis. ⋯ Liver steatosis was diagnosed in nearly one-third of HBV-infected patients treated with NA. They were significantly more likely to have obesity, diabetes, and gout compared to the non-SLD population. Despite higher baseline aminotransferases activity in the SLD group, the virological HBV activity and response to therapy were comparable.